web analytics
Velesco Pharmaceutical Services chooses SCORR as agency of record

Marketing our Analytical and Formulation Services



velesco logo pms coa 405131 lc2 copy 



Kelly Norrie

SCORR Marketing




SCORR Marketing Chosen as Agency of Record for Velesco Pharmaceutical Services


(September 23, 2008; Kearney, NE) – SCORR Marketing, a Nebraska-based strategic

marketing agency, has been selected by Velesco Pharmaceutical Services as their agency of record. SCORR will serve as a partner to Velesco with business strategy, brand development, public relations, media management and tradeshow coordination.


“We are pleased to have been named the agency of record for Velesco,” said Vice

President of SCORR Marketing, Angela Thorell. “We have unique expertise in the drug

development and clinical research industry. I am confident that our collaboration will produce outstanding results for them.”


Located in a state-of-the art former Pfizer facility in Ann Arbor, Michigan, Velesco is a contract research organization supporting early stage product development work for pharmaceutical companies. The company was founded in 2007 by pharmaceutical industry veterans and provides drug development companies with the full range of early drug development services including preformulation, analytical method development, GMP clinical supplies and consulting. Velesco’s services are designed to ensure clients reach the full therapeutic potential of their new medicines.


“We take pride in building long-term strategic partnerships built on a foundation of service,” commented Dave Barnes, Ph.D., CEO and co-founder of Velesco. “Gerry Cox, our COO and also co-founder, and I look forward to our next phase of growth and are pleased to have partnered with a firm committed to developing a valuable marketing approach.”


SCORR Marketing is a full-service marketing and public relations firm offering complete strategic communications programs to clients in a wide variety of markets and industries. For more information or to view samples of their work, visit online at www.scorrmarketing.com, or call 308.237.5567.


About SCORR Marketing

SCORR collaborates with energetic companies to develop “next-phase growth strategies” and a disciplined approach to marketing plans that insure solid incremental growth year after year, creating tangible results. SCORR’s team includes dedicated talent with worldwide experience in market development, public relations and communications, customer retention and development, corporate identity/branding, broadcast and print advertising, interactive/web design and development, as well as tradeshow/event planning and promotion.


About Velesco Pharmaceutical Services

Velesco was formed in 2007 by former Pfizer Michigan R&D colleagues and focuses on supporting the early stage work of pharmaceutical companies. Velesco’s founders, analytical chemists and drug formulation experts are pharmaceutical industry veterans with a track record of moving compounds through this significant phase of the drug development process. Velesco works with state of the art equipment in a high-quality (former Pfizer) facility. Velesco delivers on time high quality products and services, assistance with the FDA registration process and insightful consultation.  www.velescopharma.com



News and Events

Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services

Read the Press Release!

Dave Barnes, Ph.D. CEO/CSO is a featured speaker for the webinar Topical Formulation: Selection of Excipients and Better Process Understanding for Success in Commercial Manufacturing. Webinar recording available now.

View Recording!

Newly Acquired DEA Analytical Laboratory License. We are licensed to use schedules 2, 2N, 3, 3N, 4, and 5.

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services.

Roundtable: M&A trends in CDMO - Molecule to Market

New Velesco Pharma clinical manufacturing facility begins operations.

Read the press release here.

Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.

Read the interview here.

Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group.

Read the press release here.

CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!

1 new job postings! Careers

Velesco's work published

Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.

Follow Velesco

LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter FB FindUsOnFacebook 100